INS and Alzheimer disease: Based on the bidirectional regulation of the gut–brain axis, the deposition of pathological products and disruption of insulin signaling in the AD brain are mutually aggravated by the disruption of intestinal homeostasis (Hallie, Savanna, and Frank 2022).